Cripto mutant and uses thereof

Details Cripto mutant and uses thereof Cripto mutant and uses thereof

2003-03-17

2009-10-20

Goddard, Laura B (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C514S002600

Reexamination Certificate

active

07604931

ABSTRACT:
The present invention is based on the discovery that CRIPTO mutants each comprising at least one amino acid substitution from a CRIPTO polypeptide demonstrate tumor blocking activity.

REFERENCES:
patent: 5654140 (1997-08-01), Persico et al.
patent: 5854399 (1998-12-01), Salomon et al.
patent: WO-96/39420 (1996-12-01), None
patent: WO-98/33924 (1998-08-01), None
patent: WO-00/06723 (2000-02-01), None
Bowie et al (Science, 1990, 247:1306-1310).
Gura (Science, 1997, 278:1041-1042).
Jain (Sci. Am., 1994, 271:58-65).
Curti (Crit. Rev. in Oncology/Hematology, 1993, 14:29-39).
Schiffer et al, J of Biological Chemistry, 2001, 276:27769-37778.
Adkins et al, J of Clinical Investigation, 2003, 112:575-587.
Yan et al, 2002, Molecular and Cellular Biology, 4439-4449.
Schiffer et al, 2001, J Biol Chem, 276:37769-37778.
Liguori et al (Mammalian Genome, 1996, 7:344-348).
Shen (J of Clinical Investigation, 2003, 112:500-502).
Bianco et al (Cancer Research, 2003, 63:1192-1197).
Zips et al. (2005, In Vivo, 19:1-7).
Bianco et al, 2002, Mol Cell Biol, 22:2586-2597.
Adkins et al, 2003, J Clin Invest, 112:575-587.
Yeo et al, 2001, Molecular Cell, 7:949-957.
Ciardiello, F., et al., “Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides,”Proceedings of the American Association for Cancer Research., vol. 35:562 (1994).
Ciardiello, Fortunato, et al., “Inhibition of CRIPTO expression and tumorigenicity in human colon cells by antisense RNA and oligodeoxynucleotides,”Oncogene, vol. 9:291-298 (1994).
Harris, Reed J., et al., “O-Linked fucose and other post-translational modifications unique to EGF modules,”Glycobiology, vol. 3(3):219-224 (1993).
Lohmeyer, Matthias, et al., “Chemical Synthesis, Structural Modeling, and Biological Activity of the Epidermal Growth Factor-Like Domain of HumanCripto,” Biochemistry, vol. 36(13):3837-3845 (1997).
Rabbani, Shafaat A., et al., “Structural Requirements for the Growth Factor Activity of the Amino-terminal Domain of Urokinase,”The Journal of Biological Chemistry, vol. 267(20):14151-14156 (1992).
Schiffer, Susan G., et al., “Fucosylation of Cripto Is Required for Its Ability to Facilitate Nodal Signaling,”The Journal of Biological Chemistry, vol. 276(41):37769-37778 (2001).
International Search Report to PCT/US01/29066 (Nov. 9, 2002), 8 pages.

Affiliated with

Also associated with

Rating

Cripto mutant and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cripto mutant and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cripto mutant and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4081884